Laobaixing Pharmacy603883
▲ PositiveCapitalrelevance
Laobaixing launches a restricted stock incentive plan, which is typically viewed positively as it aligns management interests with shareholders.

Laobaixing has unveiled its 2026 restricted stock incentive plan, proposing to grant 9.78 million restricted shares, representing approximately 1.29% of the company's total share capital of 759 million shares, at a grant price of 6.37 yuan per share. The incentive targets no more than 230 individuals, including directors, senior management, middle management, and core staff. In the first quarter of 2026, the company achieved revenue of 5.481 billion yuan and net profit attributable to the parent company of 264 million yuan.
Laobaixing PharmacyLaobaixing launches a restricted stock incentive plan, which is typically viewed positively as it aligns management interests with shareholders.